Injective (INJ) is currently priced at $3.82, reflecting a 6.09% increase over the past 24 hours, indicating a strong upward momentum. The daily trading range shows a high of $3.89 and a low of $3.59, suggesting healthy volatility and interest among traders.

The trading volume stands at approximately $72.2 million, representing 18.91% of the market cap, which is indicative of robust market participation. The hourly moving averages reveal a positive trend, with the 8 SMA at $3.79 (+0.77%) and the 21 SMA at $3.70 (+3.14%), confirming bullish momentum over the short term.

The Relative Strength Index (RSI) for the past hour is at 69, indicating that INJ is approaching overbought territory, while the 7-day RSI at 52 suggests that the asset is in a neutral state. Over the past 30 days, INJ has appreciated by 36.23%, demonstrating strong performance and recovery potential from its previous lows.

The all-time high for INJ was $52.62, reached in March 2024, illustrating significant room for growth from the current price levels. Given the current upward trend and the positive technical indicators, the asset could be in a position for further gains if momentum continues.

Considering the data presented, the recommendation is a Buy. The combination of positive price action, strong volume, and favorable moving averages supports this rating, while the nearing overbought RSI should be monitored closely for potential corrections.